The biomarkers of gemcitabine and erlotinib treatment in advanced pancreatic cancer.
Kuniyasu Irie
No relevant relationships to disclose
Makoto Ueno
No relevant relationships to disclose
Satoshi Kobayashi
No relevant relationships to disclose
Yoshihiro Gouda
No relevant relationships to disclose
Shinichi Ohkawa
No relevant relationships to disclose
Morimoto Manabu
No relevant relationships to disclose